We found that an increased expression of 10 out of these 12 genes (i.e., PLEC, GSDMD, SCRIB, EXOSC4, CYC1, GPAA1, GRINA, HSF1, PUF60, and MAF1, while TSTA3 and NAPRT could not be mapped to the dataset) was correlated with poor overall survival breast cancer patients (Supplementary Figure S19). Here, NAPRT is linked to breast carcinoma.